Market Overview

FDA's Orange Book Doesn't Include Amarin's Vascepa NCE Status in November Report - Bloomberg

Related AMRN
Week Concludes With S&P 500 Below 2,000; Dow Below 17,000
Dow Falls Over 100 Points; Ulta Salon Shares Jump After Earnings Report

View Orange Book.

Posted-In: News FDA

 

Related Articles (AMRN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters